Status:
COMPLETED
DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors
Lead Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Collaborating Sponsors:
Azienda Policlinico Umberto I
Conditions:
Hematologic Diseases
Stem Cell Transplant Complications
Eligibility:
All Genders
Brief Summary
Retrospective observational multicentric, spontaneous non-interventional non-pharmacological Italian study. The primary objective is analysis of Anti-HLA antibodies and DSAs searching and monitoring a...
Detailed Description
The aim of the study is to evaluate, retrospectively, the activity of the Italian Centres in the search for donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic st...
Eligibility Criteria
Inclusion
- patients who underwent mismatched allogeneic transplantation, from January 2014 to June 2017
- signed the informed consent
Exclusion
- Absence of consent Written information
Key Trial Info
Start Date :
October 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 22 2021
Estimated Enrollment :
912 Patients enrolled
Trial Details
Trial ID
NCT04888286
Start Date
October 15 2018
End Date
June 22 2021
Last Update
November 25 2022
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica di Ematologia. AOU Ospedali Riuniti di Ancona
Ancona, Italy
2
Policlinico di Bari-Ematologia con trapianti
Bari, Italy
3
Divisione di Ematologia - Ospedali Papa Giovanni XXIII
Bergamo, Italy
4
Ospedale Seragnoli Malpighi
Bologna, Italy